NCT00637988View on ClinicalTrials.gov

Barrett's Esophagus - 315 - 3 Way Cross Over

PHASE4CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions

Barrett's Esophagus

Interventions

DRUG

Esomeprazole

40mg twice daily

DRUG

Aspirin

DRUG

Rofecoxib

25mg once daily

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY